Analysis of the human ferrochelatase promoter in transgenic mice

Blood

Volumn 92, Issue 1, 1998, Pages 320-328

  Magness, Scott T ^a   Tugores, Antonio ^a   Diala, Edward S ^a   Brenner, David A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; FERROCHELATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ERYTHROPOIESIS; ERYTHROPOIETIC PROTOPORPHYRIA; EXTRAMEDULLARY HEMATOPOIESIS; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HOUSEKEEPING GENE; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; TRANSGENIC MOUSE;

EID: 0032126635     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.320.413k25_320_328     Document Type: Article

References (50)

1. Brenner DA, Frasier F: Cloning of murine ferrochelatase. Proc Natl Acad Sci USA 88:849, 1991
2. Fujita H, Yamamoto M, Yamagami T, Hayashi N, Bishop TR, De Verneuil H, Yoshinaga T, Shibahara S, Morimoto R, Sassa S: Sequential activation of genes for heme pathway enzymes during erythroid differentiation of mouse Friend virus-transformed erythroleukemia cells. Biochim Biophys Acta 1090:311-316, 1991
3. Poh-Fitzpatrick MB: The "priming phenomenon" in the acute phototoxicity of erythropoietic protoporphyria. J Am Acad Dermat 21:311, 1989
4. Bloomer JR: The liver and protoporphyria. Hepatology 8:402, 1988
5. Bonkovsky HL, Bloomer JR, Eben PS, Mahoney MJ: Heme synthase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured fibroblasts. J Clin Invest 56:1139, 1975
6. Bottomley SS, Tanaka M, Everett MA: Diminsihed erythroid ferrochelatase activity in protoporphyria. J Lab Clin Med 86:126, 1975
7. Goeij AFPM, Chistianse K, Van Steveninck I: Decreased heme synthetase activity: Blood cells of patients with erythropoietic protoporphyria. EUT J Clin Invest 5:397, 1975
8. Brenner DA, Didier JM, Frasier F, Christensen SR, Evans GA, Dailey HA: A molecular defect in human protoporphyria. Am J Hum Genet 50:1203, 1992
9. Sarkany RP, Alexander GJ, Cox TM: Recessive inheritence of erythropoietic protoporphyria with liver failure. Lancet 343:1394, 1994
10. Schneider Vin X, Schafer BW, Tonz O, Minder EI: Human ferrochelatase: A novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing. Hum Genet 95:391, 1995
11. Schneider-Yin X, Taketani S, Schafer B, Minder EI: Recessive inheritence of erythropoietic protoporphyria with liver failure. Lancet 344:337, 1994
12. Wang X, Poh-Fitzpatrick M, Carriero D, Ostasiewicz L, Chen T, Taketani S, Piomelli S: A novel mutation in erythropoietic protoporphyria: An aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing. Biochim Biophys Acta 1181:198, 1993
13. Wang X, Poh-Fitzpatrick M, Tekaetani S, Chen T, Piomelli S: Screening for ferrochelatase mutations: Molecular heterogeneity of erythropoietic protoporphyria. Biochem Biophys Acta 1225:187, 1994
14. Magness ST, Tugores A, Christensen SR, Wagner-Mcpherson C, Evans GA, Naylor EW, Brenner DA: Deletion of the ferrochelatase gene in a patient with protoporphyria. Hum Mol Genet 3:1695, 1994
15. Gouya L, Deybach JC, Lamoril J, Da Silva V, Beaumont C, Grandchamp B, Nordmann Y: Modulation of the phenolype in dominant erythropoietic. Am J Hum Genet 58:292, 1996
16. Taketani S, Nazawa J, Nakahashi Y, Abe T, Tokunaga R: Structure of the human ferrochelatase gene. Exon/intron gene organization and localization of the gene to chromosome 18. EUT J Biochem 205:217, 1992
17. Tugores A, Magness ST, Brenner DA: A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene. J Biol Chem 269:30789, 1994
18. Walters M, Martin DI: Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-I/NFE-2 elements. Proc Natl Acad Sci USA89:10444, 1992
19. Ferrin LJ, Camerini-Otero RD: Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage. Science 254:1494, 1991
20. Hogan B, Costantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1986
21. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
22. Djaldetti M, Bessler H, Fishman P: Hematopoiesis in the embryonic mouse spleen. II. Alterations after phenylhydrazine administration to the mothers. Anat Rec 182:123, 1975
23. Ploemacher RE, van Soest PL: Morphological investigation on phenylhydrazine-induced erythropoiesis in the adult mouse liver. Cell Tissue Res 178:435, 1977
24. Miller IJ, Bieker JJ: A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 13:2776, 1993
25. Riddle RD, Johnson RL, Laufer E, Tabin C: Sonic hedgehog mediates the polarizing activity of the ZPA. Cell 75:1401, 1993
26. van Zonneveld AJ, Curriden SA, Loskutoff DJ: Type 1 plasminogen activator inhibitor gene: Functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci USA 85:5525, 1988
27. Bancroft JD, Stevens A: Theory and Practice of Histological Techniques (ed 4). New York, NY, Churchill Livingstone, 1996
28. Biffo S, Verdun di Cantogno L, Fasolo A: Double labeling with non-isotopic in situ hybridization and BrdU immunohistochemistry: Calmodulin (CaM) mRNA expression in post-mitotic neurons of the olfactory system. J Histochem Cytochem 40:535, 1992
29. Dzierzak E, Medvinsky A: Mouse embryonic hematopoiesis. Trends Genet 11:359, 1995
30. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F: Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375:316, 1995
31. Tun S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J: Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161, 1997
32. de Jong K, Geldwerth D, Kuypers FA: Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry 36:6768, 1997
33. Yomogida K, Ohtani H, Harigae H, Ito E, Nishimune Y, Engel JD, Yamamoto M: Developmental stage- and spermatogenic cyclespecific expression of transcription factor GATA-1 in mouse Sertoli cells. Development 120:1759, 1994
34. Furukawa T, Tokunaga R, Taketani S: Regulation of the ferrochelatase gene expression during differentiation of mouse erythroleukemia cells. Biochem Mol Biol Int 41:1161, 1997
35. Milot E, Strouboulis J, Trimborn T, Wijgerde M, de Boer E, Langeveld A, Tan-Un K, Vergeer W, Yannoutsos N, Grosveld F, Fraser P: Heterochromatin effects on the frequency and duration of LCR- mediated gene transcription. Cell 87:105, 1996
36. Geyer PK: The role of insulator elements in defining domains of gene expression. Curr Opin Genet Dev 7:242, 1997
37. Gerasimova TI, Corces VG: Boundary and insulator elements in chromosomes. Curr Opin Genet Dev 6:185, 1996
38. Jenuwein T, Forrester WC, Qiu RG, Grosschedl R: The immunoglobulin mu enhancer core establishes local factor access in nuclear chromatin independent of transcriptional stimulation. Genes Dev 7:2016, 1993
39. Wong J, Shi Y-B, Wolffe A: Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: Hormone regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J 16:3158, 1997
40. Frampton J, Walker M, Plumb M, Harrison PR: Synergy between the NF-E1 erythroid-specific transcription factor and the CACCC factor in the erythroid-specific promoter of the human porphobilinogen deaminase gene. Mol Cell Biol 10:3838, 1990
41. Fischer KD, Haese A, Nowock J: Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J Biol Chem 268:23915, 1993
42. Merika M, Orkin SH: Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol 15:2437, 1995
43. Armstrong JA, Emerson BM: NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro. Mol Cell Biol 16:5634, 1996
44. Rahuel C, Vinit M-A, Lemarchandel V, Cartron J-P, Romeo P-H: Erythroid-specific activity of the glycophorin B promoter requires GATA-1 mediated displacement of a represser. EMBO J 11:4095, 1992
45. Terajima M, Nemoto Y, Obinata M; Inducible expression of erythroid-specific mouse glycophorin gene is regulated by proximal elements and locus control region-like sequence. J Biochem 118:593, 1995
46. Porcher C, Picat C, Daegelen D, Beaumont C, Grandchamp B: Functional analysis of DNase-I hypersensitive sites at the mouse porphobilinogen deaminase gene locus. Different requirements for position-independent expression from its two promoters. J Biol Chem 270:17368, 1995
47. Beaumont C, Seyhan A, Yachou A-K, Grandchamp B, Jones R: Mouse ferritin H subunit gene: Functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells. J Biol Chem 269:20281, 1994
48. Youssoufian H: Further characterization of cis-acting regulatory sequences in the genomic locus of the murine erythropoietin receptor: Evidence for stage-specific regulation. Blood 83:1428, 1994
49. Sowden J, Edwards M, Morrison K, Butterworth PH, Edwards YH: Erythroid expression and DNAasel-hypersensitive sites of the carbonic anhydrase 1 gene. Biochem J 288:545, 1992
50. Martin DI, Fiering S, Groudine M: Regulation of beta-globin gene expression: Straightening out the locus. Curr Opin Genet Dev 6:488, 1996